Cite
APA Citation
Maamra, M., Benayad, O. M., Matthews, D., Kettleborough, C., Atkinson, J., Cain, K., Bon, H., Brand, H., Parkinson, M., Watson, P. F., & Johnson, T. S. (2022). transglutaminase 2: Development of therapeutic antibodies reveals four inhibitory epitopes and confirms extracellular function in fibrotic remodelling. British journal of pharmacology, 179, 2697–2712. http://access.bl.uk/ark:/81055/vdc_100155150127.0x000041